| 5001 | OLR1 levels | GCST90470122 | 0.11 |
| 5002 | CTRB1 levels | GCST90468905 | 0.11 |
| 5003 | FKBP1B/TGFB1 ratio | GCST90314836 | 0.11 |
| 5004 | Hemoglobin A1c levels | GCST90018738 | 0.11 |
| 5005 | MED18 levels | GCST90469880 | 0.11 |
| 5006 | Total cholesterol levels in medium VLDL | GCST90132689 | 0.11 |
| 5007 | Concentration of medium LDL particles (UKB data field 23537) | GCST90269634 | 0.11 |
| 5008 | IDP dMRI TBSS FA Tapetum R | GCST90003923 | 0.11 |
| 5009 | MIF levels | GCST90089018 | 0.11 |
| 5010 | Cholesterol to total lipids ratio in very large VLDL | GCST90093017 | 0.11 |
| 5011 | Sphingomyelin_33:1_[M+H]1+ levels | GCST90060229 | 0.11 |
| 5012 | eGFR in diabetes mellitus (loose) (minimal adjustment) | GCST90624783 | 0.11 |
| 5013 | Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000294 | 0.11 |
| 5014 | Triacylglycerol_53:2_[M+NH4]1+ levels | GCST90060531 | 0.11 |
| 5015 | SNX5 levels | GCST90470702 | 0.11 |
| 5016 | High light scatter reticulocyte percentage | Blood count | UKBB00000327 | 0.11 |
| 5017 | Autorefraction - 3mm weak meridian (right) | Eyesight | UKBB00000070 | 0.11 |
| 5018 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 0.11 |
| 5019 | Glycated haemoglobin (HbA1c) | Blood biochemistry | UKBB00000289 | 0.11 |
| 5020 | Volume of right central nucleus | GCST90475024 | 0.11 |
| 5021 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28) | GCST90320847 | 0.11 |
| 5022 | GMFG levels | GCST90469366 | 0.11 |
| 5023 | Bicarbonate (maximum, inv-norm transformed) | GCST90475145 | 0.11 |
| 5024 | Diacylglycerol_34:2_[M+H-H2O]1+ levels | GCST90060178 | 0.11 |
| 5025 | Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | Medication | UKBB00000455 | 0.11 |
| 5026 | Tooth agenesis EXCLUDE clefts and syndromes | FING00001368 | 0.11 |
| 5027 | DTI TBSS FA Posterior thalamic radiation L | GCST90384409 | 0.11 |
| 5028 | wg rh intensity-contrast fusiform | GCST90003833 | 0.11 |
| 5029 | CDH17/PECAM1 ratio | GCST90313942 | 0.11 |
| 5030 | HNRNPUL1 levels | GCST90469470 | 0.11 |
| 5031 | Glucose levels | GCST90018735 | 0.11 |
| 5032 | Codeine or tramadol medication | FING00000311 | 0.11 |
| 5033 | Primary coxarthrosis, bilateral | FING00001212 | 0.11 |
| 5034 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320687 | 0.11 |
| 5035 | IDP dMRI TBSS OD Posterior limb of internal capsule R | GCST90004420 | 0.11 |
| 5036 | DTI autoptx FA ptr l tract | GCST90385131 | 0.11 |
| 5037 | Pain and other conditions associated with female genital organs and menstrual cycle | FING00001136 | 0.11 |
| 5038 | Acute upper respiratory infections of multiple and unspecified sites | FING00000035 | 0.11 |
| 5039 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497768 | 0.11 |
| 5040 | CRTAM/FCRL6 ratio | GCST90314274 | 0.11 |
| 5041 | GRP levels | GCST90241242 | 0.11 |
| 5042 | IL1RL1 levels | GCST90241581 | 0.11 |
| 5043 | APOA levels | GCST90468061 | 0.11 |
| 5044 | CDH17/DSG2 ratio | GCST90313939 | 0.11 |
| 5045 | CELA2A levels | GCST90468701 | 0.11 |
| 5046 | MESD/VASH1 ratio | GCST90315425 | 0.11 |
| 5047 | Phospholipids in LDL | GCST90498432 | 0.10 |
| 5048 | Hair colour (natural, before greying): Black (UKB data field 1747_5) | GCST90041840 | 0.10 |
| 5049 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 0.10 |
| 5050 | Triglyceride levels | GCST90278645 | 0.10 |
| 5051 | RND3 levels | GCST90422230 | 0.10 |
| 5052 | Oral glucose tolerance test-1h | GCST90297789 | 0.10 |
| 5053 | CLEC1B/NSFL1C ratio | GCST90314099 | 0.10 |
| 5054 | Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482) | GCST90269579 | 0.10 |
| 5055 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502043 | 0.10 |
| 5056 | CPA1 levels | GCST90468836 | 0.10 |
| 5057 | Right ventricular peak atrial filling rate | GCST90268119 | 0.10 |
| 5058 | AK1/NSFL1C ratio | GCST90313224 | 0.10 |
| 5059 | Cholesterol in small LDL (UKB data field 23547) | GCST90269644 | 0.10 |
| 5060 | Cholesterol esters in very large HDL | GCST90500354 | 0.10 |
| 5061 | DTI autoptx L3 slf l tract | GCST90385214 | 0.10 |
| 5062 | CD79B/ICAM3 ratio | GCST90313901 | 0.10 |
| 5063 | aseg global volume CSF | GCST90002603 | 0.10 |
| 5064 | GPKOW levels | GCST90469392 | 0.10 |
| 5065 | KLK14 levels | GCST90427428 | 0.10 |
| 5066 | Cholesteryl esters to total lipids ratio in medium VLDL | GCST90092919 | 0.10 |
| 5067 | Total lipid levels in medium LDL | GCST90092910 | 0.10 |
| 5068 | EPO/TFRC ratio | GCST90314684 | 0.10 |
| 5069 | Diastolic blood pressure | GCST90472778 | 0.10 |
| 5070 | MASP1 levels | GCST90469863 | 0.10 |
| 5071 | MAX/STK24 ratio | GCST90315404 | 0.10 |
| 5072 | DTI TBSS L2 Posterior thalamic radiation L | GCST90384505 | 0.10 |
| 5073 | CSF2 levels | GCST90468884 | 0.10 |
| 5074 | Deferral due to hypohemoglobinemia in blood donors | GCST90104113 | 0.10 |
| 5075 | Prescriptions - antispasmodic | UKBB00000666 | 0.10 |
| 5076 | Any dementia (more control exclusions) | FING00000099 | 0.10 |
| 5077 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T92 | ECGA000092 | 0.10 |
| 5078 | SRP14 levels | GCST90470742 | 0.10 |
| 5079 | Free cholesterol to total lipids in IDL percentage (UKB data field 23612) | GCST90269709 | 0.10 |
| 5080 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 0.10 |
| 5081 | Left ventricular end systole inferior wall thickness | GCST90278509 | 0.10 |
| 5082 | wg lh intensity-contrast lateraloccipital | GCST90003802 | 0.10 |
| 5083 | STAT5B levels | GCST90470759 | 0.10 |
| 5084 | CLPP levels | GCST90468785 | 0.10 |
| 5085 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76 | ECGU000076 | 0.10 |
| 5086 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172 | ECGU000172 | 0.10 |
| 5087 | ECHDC3 levels | GCST90469062 | 0.10 |
| 5088 | DTI autoptx L3 slf r tract | GCST90385215 | 0.10 |
| 5089 | CNDP1 levels | GCST90468796 | 0.10 |
| 5090 | TNFRSF1A levels | GCST90012015 | 0.10 |
| 5091 | Pain medicine use during menstruation | GCST006637 | 0.10 |
| 5092 | Autorefraction - 3mm weak meridian (left) | Eyesight | UKBB00000069 | 0.10 |
| 5093 | aparc-Desikan rh area lingual | GCST90003119 | 0.10 |
| 5094 | DOK2/GRAP2 ratio | GCST90314531 | 0.10 |
| 5095 | CFB levels | GCST90240778 | 0.10 |
| 5096 | Cholesteryl esters in large HDL (UKB data field 23562) | GCST90269659 | 0.10 |
| 5097 | HEXIM1/TBL1X ratio | GCST90315053 | 0.10 |
| 5098 | Cholesteryl esters to total lipids ratio in medium LDL | GCST90092907 | 0.10 |
| 5099 | Cholesteryl esters in small VLDL (UKB data field 23513) | GCST90269610 | 0.10 |
| 5100 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497732 | 0.10 |
| 5101 | 1-arachidonoylglycerophosphoinositol levels | GCST90243754 | 0.10 |
| 5102 | Systolic blood pressure | GCST90310294 | 0.10 |
| 5103 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 0.10 |
| 5104 | Diabetes mellitus (UKB data field 2443) | GCST90043627 | 0.10 |
| 5105 | wg rh intensity-contrast superiorfrontal | GCST90003854 | 0.10 |
| 5106 | EGLN1/PIK3AP1 ratio | GCST90314619 | 0.10 |
| 5107 | Cholesterol levels in medium LDL | GCST90092904 | 0.10 |
| 5108 | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302719 | 0.10 |
| 5109 | CAMK1D levels | GCST90240556 | 0.10 |
| 5110 | T1 CAT volume L LateralOccipitalCortexinferiordivision | GCST90384044 | 0.10 |
| 5111 | MAP2K1 levels | GCST90469851 | 0.10 |
| 5112 | GALNT10/IGSF3 ratio | GCST90314914 | 0.10 |
| 5113 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 0.10 |
| 5114 | DTI autoptx L1 ifo r tract | GCST90385152 | 0.10 |
| 5115 | ICD10 O26.6: Liver disorders in pregnancy, childbirth and puerperium | GCST90454237 | 0.10 |
| 5116 | CTRL levels | GCST90468907 | 0.10 |
| 5117 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T207 | ECGU000207 | 0.10 |
| 5118 | PVR levels | GCST90470394 | 0.10 |
| 5119 | Volume of right basal nucleus | GCST90475012 | 0.10 |
| 5120 | Congenital malformations of genital organs | FING00000333 | 0.10 |
| 5121 | Medication use (antithrombotic agents) | GCST90018762 | 0.09 |
| 5122 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2 | ECGU000002 | 0.09 |
| 5123 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320885 | 0.09 |
| 5124 | Been in a confiding relationship as an adult | Traumatic events | UKBB00000088 | 0.09 |
| 5125 | APOM/MCAM ratio | GCST90313315 | 0.09 |
| 5126 | Docosahexaenoic acid to total fatty acids percentage | GCST90502280 | 0.09 |
| 5127 | Keloid | GCST90652488 | 0.09 |
| 5128 | PSAPL1 levels | GCST90470350 | 0.09 |
| 5129 | GLO1 levels | GCST90469358 | 0.09 |
| 5130 | aparc-pial rh area lingual | GCST90003186 | 0.09 |
| 5131 | Sleep apnea with BMI < 30 | GCST90624797 | 0.09 |
| 5132 | wg lh intensity-contrast frontalpole | GCST90003823 | 0.09 |
| 5133 | PDGFB/SNAP29 ratio | GCST90315627 | 0.09 |
| 5134 | FGF19 levels | GCST90469220 | 0.09 |
| 5135 | DIABLO/PDGFB ratio | GCST90314468 | 0.09 |
| 5136 | Follicle stimulating hormone levels | GCST90483476 | 0.09 |
| 5137 | Linoleic acid to total fatty acids percentage | GCST90502017 | 0.09 |
| 5138 | Cholesteryl ester levels in small LDL | GCST90092958 | 0.09 |
| 5139 | Total lipid levels in medium VLDL | GCST90092922 | 0.09 |
| 5140 | Free androgen index | GCST90239823 | 0.09 |
| 5141 | Other bacterial diseases | FING00000968 | 0.09 |
| 5142 | Total cholesterol response to statins (relative logarithmic difference) | GCST90455608 | 0.09 |
| 5143 | Total cerebellar volume (excluding Crus I vermis) | GCST90020190 | 0.09 |
| 5144 | LPCAT2 levels | GCST90241841 | 0.09 |
| 5145 | Cholesterol levels in very large VLDL | GCST90500517 | 0.09 |
| 5146 | DOK2/PDLIM7 ratio | GCST90314535 | 0.09 |
| 5147 | MUC13 levels | GCST90469963 | 0.09 |
| 5148 | ITGB1/TFPI ratio | GCST90315231 | 0.09 |
| 5149 | Other disorders of eyelids (PheCode 374) | GCST90475890 | 0.09 |
| 5150 | LDL cholesterol levels | GCST90498346 | 0.09 |
| 5151 | Haematocrit percentage (UKB data field 30030) | GCST90468073 | 0.09 |
| 5152 | (R)-3-hydroxybutyrylcarnitine levels | GCST90199930 | 0.09 |
| 5153 | Total lipids in large HDL | GCST90497815 | 0.09 |
| 5154 | Triglycerides in small LDL (UKB data field 23550) | GCST90269647 | 0.09 |
| 5155 | Otosclerosis | GCST90129575 | 0.09 |
| 5156 | GBP6 levels | GCST90241368 | 0.09 |
| 5157 | EFEMP1/TGFBR3 ratio | GCST90314597 | 0.09 |
| 5158 | Estradiol levels | GCST90012105 | 0.09 |
| 5159 | Liver condition (ex. cirrhosis) | GCST90475270 | 0.09 |
| 5160 | wg lh intensity-contrast postcentral | GCST90003813 | 0.09 |
| 5161 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 0.09 |
| 5162 | Biological Mother: Cancer, Skin | GCST90475487 | 0.09 |
| 5163 | MMP13 levels | GCST90469917 | 0.09 |
| 5164 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T91 | ECGA000091 | 0.09 |
| 5165 | SIL1 levels | GCST90470638 | 0.09 |
| 5166 | FSTL3/SPON2 ratio | GCST90314884 | 0.09 |
| 5167 | HGF/PDGFB ratio | GCST90315058 | 0.09 |
| 5168 | aparc-pial rh area lateraloccipital | GCST90003184 | 0.09 |
| 5169 | CCR2 on CD14+ CD16- monocyte | GCST90002004 | 0.09 |
| 5170 | Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596) | GCST90269693 | 0.09 |
| 5171 | Cholesterol to Total Lipids in IDL percentage | GCST90497518 | 0.09 |
| 5172 | Type 1 diabetes | GCST90432066 | 0.09 |
| 5173 | CASP3/PDGFA ratio | GCST90313637 | 0.09 |
| 5174 | Concentration of small LDL particles (UKB data field 23544) | GCST90269641 | 0.09 |
| 5175 | Cholesterol in medium LDL (UKB data field 23540) | GCST90269637 | 0.09 |
| 5176 | Linoleic acid to total fatty acids percentage (UKB data field 23456) | GCST90269553 | 0.09 |
| 5177 | Other disorders of circulatory system | circulatory system | UKBB00000607 | 0.09 |
| 5178 | CFI levels | GCST90468730 | 0.09 |
| 5179 | Phospholipids in medium VLDL (UKB data field 23504) | GCST90269601 | 0.09 |
| 5180 | CEP170 levels | GCST90468711 | 0.09 |
| 5181 | Phosphatidylinositol (20:0_20:4) levels | GCST90025083 | 0.09 |
| 5182 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 0.09 |
| 5183 | Omega-3 fatty acids to total fatty acids percentage | GCST90499155 | 0.09 |
| 5184 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443 | ECGU000443 | 0.09 |
| 5185 | Deep endometriosis | FING00000382 | 0.09 |
| 5186 | SERPINC1 levels | GCST90470594 | 0.09 |
| 5187 | TNFSF10 levels | GCST90470917 | 0.09 |
| 5188 | Phospholipids in medium HDL | GCST90498635 | 0.09 |
| 5189 | Left-hemisphere limbic network to amygdala white-matter structural connectivity | GCST90302741 | 0.09 |
| 5190 | Phospholipids in very large VLDL | GCST90500644 | 0.09 |
| 5191 | CXCL16 levels | GCST90240524 | 0.09 |
| 5192 | Other heart diseases | FING00001057 | 0.09 |
| 5193 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98) | GCST90320661 | 0.09 |
| 5194 | Omega-6 fatty acid levels | GCST90502502 | 0.09 |
| 5195 | Calculus of kidney | genitourinary | UKBB00000115 | 0.09 |
| 5196 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 0.09 |
| 5197 | Linoleic acid to total fatty acids percentage | GCST90502320 | 0.09 |
| 5198 | rfMRI amplitudes (ICA100 node 35) | GCST90004623 | 0.09 |
| 5199 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457 | ECGU000457 | 0.09 |
| 5200 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 0.09 |
| 5201 | Treatment/medication code - lisinopril | Medications | UKBB00000850 | 0.09 |
| 5202 | Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers) | FING00000864 | 0.09 |
| 5203 | Fasting glucose | GCST90278628 | 0.09 |
| 5204 | CA1/TGM2 ratio | GCST90313575 | 0.09 |
| 5205 | Hypercalcemia (PheCode 275.6) | GCST90475748 | 0.09 |
| 5206 | NPHS2 levels | GCST90470071 | 0.09 |
| 5207 | X-21471 levels | GCST90200586 | 0.09 |
| 5208 | ADAMTS4 levels | GCST90468226 | 0.09 |
| 5209 | Linoleic acid levels | GCST90502294 | 0.09 |
| 5210 | Enteropathic arthropathies | FING00000508 | 0.09 |
| 5211 | Concentration of large LDL particles | GCST90498037 | 0.09 |
| 5212 | Saturated fatty acids to total fatty acids percentage | GCST90502199 | 0.09 |
| 5213 | DEFA1_DEFA1B/LCN2 ratio | GCST90314454 | 0.08 |
| 5214 | MAMDC4 levels | GCST90469842 | 0.08 |
| 5215 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502580 | 0.08 |
| 5216 | IGFBPL1 levels | GCST90469533 | 0.08 |
| 5217 | Chronic obstructive pulmonary disease | GCST90018587 | 0.08 |
| 5218 | HPCAL1/LAT ratio | GCST90315072 | 0.08 |
| 5219 | Cholesterol levels in very small VLDL | GCST90500712 | 0.08 |
| 5220 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203 | ECGA000203 | 0.08 |
| 5221 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100 | ECGU000100 | 0.08 |
| 5222 | Iliac isthmus breadth | GCST90448907 | 0.08 |
| 5223 | MCAM/NTRK3 ratio | GCST90315409 | 0.08 |
| 5224 | Vertical cup-disc ratio | GCST004075 | 0.08 |
| 5225 | Type 1 diabetes | GCST90014023 | 0.08 |
| 5226 | COX5B/FXN ratio | GCST90314199 | 0.08 |
| 5227 | KLK4 levels | GCST90469704 | 0.08 |
| 5228 | Acute pancreatitis | FING00000027 | 0.08 |
| 5229 | Longitudinal peak diastolic strain rate | GCST90019013 | 0.08 |
| 5230 | Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2) | GCST90475770 | 0.08 |
| 5231 | Abscess of anal and rectal regions | FING00000005 | 0.08 |
| 5232 | GSTA1/KRT18 ratio | GCST90314993 | 0.08 |
| 5233 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499569 | 0.08 |
| 5234 | Mean corpuscular volume | Blood count | UKBB00000449 | 0.08 |
| 5235 | THOP1 levels | GCST90470856 | 0.08 |
| 5236 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448 | ECGU000448 | 0.08 |
| 5237 | Breast cancer | GCST90011804 | 0.08 |
| 5238 | SERPINI2 levels | GCST90470603 | 0.08 |
| 5239 | NID1/TIMP3 ratio | GCST90315543 | 0.08 |
| 5240 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463 | ECGU000463 | 0.08 |
| 5241 | CCBL2 levels | GCST90241722 | 0.08 |
| 5242 | FADD/MGLL ratio | GCST90314768 | 0.08 |
| 5243 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 0.08 |
| 5244 | CSTB levels | GCST90179272 | 0.08 |
| 5245 | MPO levels | GCST90469937 | 0.08 |
| 5246 | Right ventricular end systolic volume | GCST90134589 | 0.08 |
| 5247 | IDP dMRI TBSS FA Sagittal stratum L | GCST90003908 | 0.08 |
| 5248 | DBNL/VASH1 ratio | GCST90314427 | 0.08 |
| 5249 | TNFRSF10A levels | GCST90470899 | 0.08 |
| 5250 | Osteoarthritis (hip) | GCST007091 | 0.08 |
| 5251 | AGXT/GSTA1 ratio | GCST90313206 | 0.08 |
| 5252 | Phospholipids to total lipids ratio in medium LDL | GCST90092913 | 0.08 |
| 5253 | Cholesterol esters in very small VLDL | GCST90500749 | 0.08 |
| 5254 | MMP7 levels | GCST90469921 | 0.08 |
| 5255 | Volume of right lateral nucleus | GCST90475039 | 0.08 |
| 5256 | Saturated fatty acids to total fatty acids percentage | GCST90502700 | 0.08 |
| 5257 | Phosphatidylcholine diacyl C36:4 levels | GCST90240040 | 0.08 |
| 5258 | Diabetes diagnosed by doctor | Medical conditions | UKBB00000168 | 0.08 |
| 5259 | F7/F9 ratio | GCST90314743 | 0.08 |
| 5260 | CRLF1 levels | GCST90468868 | 0.08 |
| 5261 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 89) | GCST90320652 | 0.08 |
| 5262 | IDP dMRI ProbtrackX MD cst r | GCST90004228 | 0.08 |
| 5263 | LTBP2/PDGFRA ratio | GCST90315338 | 0.08 |
| 5264 | SPOCK2 levels | GCST90242987 | 0.08 |
| 5265 | Cholesteryl Esters in LDL | GCST90498374 | 0.08 |
| 5266 | BPIFB1/GLRX ratio | GCST90313530 | 0.08 |
| 5267 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110) | GCST90320929 | 0.08 |
| 5268 | Concentration of very small VLDL particles (UKB data field 23516) | GCST90269613 | 0.08 |
| 5269 | MVK/SERPINE1 ratio | GCST90315505 | 0.08 |
| 5270 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36) | GCST90320855 | 0.08 |
| 5271 | Blood cell traits latent factor 14 (red cell) | GCST90559256 | 0.08 |
| 5272 | Average diameter for VLDL particles | GCST90500290 | 0.08 |
| 5273 | ITIH3 levels | GCST90469650 | 0.08 |
| 5274 | Triglycerides in medium VLDL | GCST90499065 | 0.08 |
| 5275 | ASGR1/GGT5 ratio | GCST90313365 | 0.08 |
| 5276 | Triglycerides to total lipids ratio in small VLDL | GCST90092979 | 0.08 |
| 5277 | PRDX5 levels | GCST90470318 | 0.08 |
| 5278 | Volume of right whole amygdala | GCST90475054 | 0.08 |
| 5279 | CCL4 levels | GCST90012052 | 0.08 |
| 5280 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222 | ECGU000222 | 0.08 |
| 5281 | T1 FreeSurfer a2009s lh G cuneus area | GCST90384678 | 0.08 |
| 5282 | Birth weight | GCST007557 | 0.08 |
| 5283 | BA-exvivo rh volume BA3b | GCST90002852 | 0.08 |
| 5284 | Phospholipids in medium HDL | GCST90498641 | 0.08 |
| 5285 | PLAUR levels | GCST90470251 | 0.08 |
| 5286 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 0.08 |
| 5287 | EBAG9/HBEGF ratio | GCST90314565 | 0.08 |
| 5288 | T1 FreeSurfer DKT rh pericalcarine area | GCST90384305 | 0.08 |
| 5289 | Sleep apnea syndrome | GCST90267361 | 0.08 |
| 5290 | SFTPD levels | GCST90470614 | 0.08 |
| 5291 | Heart failure, strict | FING00000606 | 0.08 |
| 5292 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462 | ECGU000462 | 0.08 |
| 5293 | Hair colour (natural, before greying): Light brown (UKB data field 1747_3) | GCST90041838 | 0.08 |
| 5294 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173 | ECGU000173 | 0.08 |
| 5295 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 0.08 |
| 5296 | IZUMO4 levels | GCST90423792 | 0.08 |
| 5297 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123) | GCST90320686 | 0.08 |
| 5298 | ThalamNuclei lh volume PuI | GCST90002714 | 0.08 |
| 5299 | Triglycerides in very large HDL | GCST90500482 | 0.08 |
| 5300 | HDL x low social support interaction (2df test) | GCST90570669 | 0.08 |
| 5301 | AKT3 levels | GCST90468278 | 0.08 |
| 5302 | Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486) | GCST90269583 | 0.08 |
| 5303 | TNFRSF13C levels | GCST90470906 | 0.08 |
| 5304 | MAPRE3 levels | GCST90469859 | 0.08 |
| 5305 | LBP levels | GCST90469743 | 0.08 |
| 5306 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T99 | ECGU000099 | 0.08 |
| 5307 | T1 FreeSurfer DK rh supramarginal volume | GCST90385787 | 0.07 |
| 5308 | FURIN/INHBC ratio | GCST90314886 | 0.07 |
| 5309 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5) | GCST90320568 | 0.07 |
| 5310 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels | GCST90200060 | 0.07 |
| 5311 | VEGFD levels | GCST90012069 | 0.07 |
| 5312 | Straight vs curly hair | GCST006094 | 0.07 |
| 5313 | EPHB6/TNFRSF9 ratio | GCST90314682 | 0.07 |
| 5314 | ECG, heart rate | ECG during exercise | UKBB00000204 | 0.07 |
| 5315 | BCR/ICA1 ratio | GCST90313493 | 0.07 |
| 5316 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 0.07 |
| 5317 | Other disorders of amino-acid metabolism | FING00001014 | 0.07 |
| 5318 | Macular puckering of retina (PheCode 362.26) | GCST90475854 | 0.07 |
| 5319 | Other hammer toe(s) (acquired) | FING00001054 | 0.07 |
| 5320 | Total triglycerides levels | GCST90092992 | 0.07 |
| 5321 | Total Lipids in LDL | GCST90498396 | 0.07 |
| 5322 | CTSO levels | GCST90179277 | 0.07 |
| 5323 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 0.07 |
| 5324 | Senile cataract | FING00001290 | 0.07 |
| 5325 | Total lipids in small LDL | GCST90499652 | 0.07 |
| 5326 | LGALS7_LGALS7B/WFDC12 ratio | GCST90315317 | 0.07 |
| 5327 | Coeliac disease | FING00000312 | 0.07 |
| 5328 | CTRC levels | GCST90468906 | 0.07 |
| 5329 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229 | ECGU000229 | 0.07 |
| 5330 | BCR/VASH1 ratio | GCST90313499 | 0.07 |
| 5331 | Concentration of very small VLDL particles | GCST90093035 | 0.07 |
| 5332 | Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093045 | 0.07 |
| 5333 | IDP dMRI ProbtrackX L3 cst l | GCST90004308 | 0.07 |
| 5334 | PTPRR levels | GCST90470386 | 0.07 |
| 5335 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450 | ECGU000450 | 0.07 |
| 5336 | DIPK2B levels | GCST90468996 | 0.07 |
| 5337 | aparc-a2009s rh area S-parieto-occipital | GCST90003435 | 0.07 |
| 5338 | Average diameter for LDL particles | GCST90498457 | 0.07 |
| 5339 | Mean corpuscular hemoglobin | GCST90018744 | 0.07 |
| 5340 | Valine levels | GCST90243453 | 0.07 |
| 5341 | Coxarthrosis, primary | FING00000363 | 0.07 |
| 5342 | DAG1/HBEGF ratio | GCST90314376 | 0.07 |
| 5343 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 0.07 |
| 5344 | Parental longevity (mother's attained age) | GCST006696 | 0.07 |
| 5345 | rfMRI amplitudes (ICA100 node 28) | GCST90004616 | 0.07 |
| 5346 | Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels | GCST90060243 | 0.07 |
| 5347 | T1 FreeSurfer DKT lh superiortemporal thickness | GCST90384252 | 0.07 |
| 5348 | PPT1 levels | GCST90427718 | 0.07 |
| 5349 | MAD1L1/POLR2F ratio | GCST90315354 | 0.07 |
| 5350 | Recent feelings of inadequacy | Depression | UKBB00000739 | 0.07 |
| 5351 | X-16087 levels | GCST90200537 | 0.07 |
| 5352 | Lactate levels (UKB data field 23471) | GCST90269568 | 0.07 |
| 5353 | Phospholipids to total lipids in large VLDL percentage (UKB data field 23589) | GCST90269686 | 0.07 |
| 5354 | IDP dMRI TBSS MD Fornix | GCST90004032 | 0.07 |
| 5355 | IFNGR1/THBD ratio | GCST90315130 | 0.07 |
| 5356 | EFNB2 levels | GCST90469082 | 0.07 |
| 5357 | MYOM2 levels | GCST90469985 | 0.07 |
| 5358 | Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levels | GCST90060345 | 0.07 |
| 5359 | IDP dMRI TBSS FA Fornix | GCST90003882 | 0.07 |
| 5360 | Cholesterol in Medium VLDL | GCST90498903 | 0.07 |
| 5361 | Free cholesterol in medium VLDL | GCST90498965 | 0.07 |
| 5362 | AXIN1/IKBKG ratio | GCST90313409 | 0.07 |
| 5363 | Glucose levels | GCST90092819 | 0.07 |
| 5364 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 0.07 |
| 5365 | Total lipids in medium LDL (UKB data field 23538) | GCST90269635 | 0.07 |
| 5366 | LAMA4 levels | GCST90469731 | 0.07 |
| 5367 | EPCAM levels | GCST90469126 | 0.07 |
| 5368 | PSME1 levels | GCST90470360 | 0.07 |
| 5369 | SEMA4C levels | GCST90470572 | 0.07 |
| 5370 | Pyruvate levels (UKB data field 23472) | GCST90269569 | 0.07 |
| 5371 | Triglycerides to total lipids ratio in very large VLDL | GCST90093027 | 0.07 |
| 5372 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66 | ECGU000066 | 0.07 |
| 5373 | Lactate levels | GCST90092882 | 0.07 |
| 5374 | CRKL/PLA2G4A ratio | GCST90314271 | 0.07 |
| 5375 | ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cyst | GCST90454215 | 0.07 |
| 5376 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77 | ECGU000077 | 0.07 |
| 5377 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447 | ECGU000447 | 0.07 |
| 5378 | Docosahexaenoic acid levels | GCST90502254 | 0.07 |
| 5379 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 0.07 |
| 5380 | Illnesses of father - Diabetes | Family history | UKBB00000341 | 0.07 |
| 5381 | Type1 diabetes, definitions combined, early onset | FING00001384 | 0.07 |
| 5382 | PROC levels | GCST90470335 | 0.07 |
| 5383 | Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels | GCST90060395 | 0.07 |
| 5384 | T1 FreeSurfer DKT rh supramarginal volume | GCST90384377 | 0.07 |
| 5385 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128 | ECGU000128 | 0.07 |
| 5386 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T241 | ECGU000241 | 0.07 |
| 5387 | DTI autoptx MD ptr r tract | GCST90385240 | 0.07 |
| 5388 | VLDL cholesterol levels (UKB data field 23403) | GCST90269500 | 0.07 |
| 5389 | Omega-6 fatty acids to total fatty acids percentage | GCST90502544 | 0.07 |
| 5390 | wg lh intensity-contrast fusiform | GCST90003798 | 0.07 |
| 5391 | CD58/ROR1 ratio | GCST90313854 | 0.07 |
| 5392 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174 | ECGU000174 | 0.07 |
| 5393 | Butyrylcarnitine levels | GCST90243589 | 0.07 |
| 5394 | Pulmonary tuberculosis | GCST90018672 | 0.07 |
| 5395 | Ratio of linoleic acid to total fatty acids | GCST90092881 | 0.07 |
| 5396 | Cholesteryl esters in very large VLDL | GCST90500556 | 0.07 |
| 5397 | CELA3A/CPA1 ratio | GCST90314009 | 0.07 |
| 5398 | Triglycerides to total lipids in small VLDL percentage (UKB data field 23603) | GCST90269700 | 0.07 |
| 5399 | F10 levels | GCST90469163 | 0.07 |
| 5400 | A1BG levels | GCST90468185 | 0.07 |
| 5401 | Dupuytren's disease | GCST90301252 | 0.07 |
| 5402 | CEP43 levels | GCST90468715 | 0.07 |
| 5403 | Benign leiomyoma with endometriosis (controls excluding all cancers) | FING00000145 | 0.07 |
| 5404 | ICD10 N81: Female genital prolapse | GCST90454214 | 0.07 |
| 5405 | Cholesteryl esters in small LDL (UKB data field 23548) | GCST90269645 | 0.07 |
| 5406 | Prescriptions - ACE inhibitor|anti-hypertensive | UKBB00000657 | 0.07 |
| 5407 | Total testosterone levels | GCST90012113 | 0.07 |
| 5408 | Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211) | GCST90043552 | 0.07 |
| 5409 | CD55/PTGDS ratio | GCST90313847 | 0.07 |
| 5410 | DTI TBSS FA Uncinate fasciculus L | GCST90384425 | 0.07 |
| 5411 | Urinary incontinence (PheCode 599.4) | GCST90476152 | 0.07 |
| 5412 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320887 | 0.07 |
| 5413 | RAB10 levels | GCST90470403 | 0.07 |
| 5414 | Degree of unsaturation | GCST90502748 | 0.06 |
| 5415 | Polyunsaturated fatty acid levels | GCST90499271 | 0.06 |
| 5416 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213 | ECGU000213 | 0.06 |
| 5417 | aparc-pial lh area parstriangularis | GCST90003160 | 0.06 |
| 5418 | wg rh intensity-contrast parstriangularis | GCST90003846 | 0.06 |
| 5419 | Total Dihexosylceramide levels | GCST90025821 | 0.06 |
| 5420 | CALCB levels | GCST90468529 | 0.06 |
| 5421 | MANF levels | GCST90469846 | 0.06 |
| 5422 | Omega-6 fatty acid levels | GCST90092933 | 0.06 |
| 5423 | aseg lh volume choroid-plexus | GCST90002629 | 0.06 |
| 5424 | Free cholesterol in very small VLDL | GCST90500774 | 0.06 |
| 5425 | AGRP/CCN1 ratio | GCST90313202 | 0.06 |
| 5426 | Total lipid levels in lipoprotein particles | GCST90092989 | 0.06 |
| 5427 | Cystatin C production | GCST90267986 | 0.06 |
| 5428 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116) | GCST90320935 | 0.06 |
| 5429 | Left ventricular end diastole inferoseptal wall thickness | GCST90278514 | 0.06 |
| 5430 | Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616) | GCST90269713 | 0.06 |
| 5431 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T211 | ECGU000211 | 0.06 |
| 5432 | Cholesterol levels in small HDL | GCST90092944 | 0.06 |
| 5433 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 0.06 |
| 5434 | PI3 levels | GCST90470230 | 0.06 |
| 5435 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 0.06 |
| 5436 | DTI TBSS MO Medial lemniscus R | GCST90384628 | 0.06 |
| 5437 | Omega-3 fatty acid levels | GCST90502437 | 0.06 |
| 5438 | Total lipids in small LDL (UKB data field 23545) | GCST90269642 | 0.06 |
| 5439 | QPCT/RNASET2 ratio | GCST90315758 | 0.06 |
| 5440 | PITHD1 levels | GCST90470239 | 0.06 |
| 5441 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 0.06 |
| 5442 | CANT1/HSPB1 ratio | GCST90313617 | 0.06 |
| 5443 | Chronic lower respiratory diseases | FING00000290 | 0.06 |
| 5444 | Cylindrical power (right) | Autorefraction | UKBB00000162 | 0.06 |
| 5445 | Triglyceride levels in medium LDL | GCST90092914 | 0.06 |
| 5446 | wg rh intensity-contrast inferiorparietal | GCST90003834 | 0.06 |
| 5447 | Height (weighted GWA) | GCST90267285 | 0.06 |
| 5448 | Omega-6 fatty acid levels | GCST90502094 | 0.06 |
| 5449 | GFER/TRIAP1 ratio | GCST90314921 | 0.06 |
| 5450 | CDH17/SPINT1 ratio | GCST90313944 | 0.06 |
| 5451 | INSR levels | GCST90241509 | 0.06 |
| 5452 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 0.06 |
| 5453 | Plasma pregnenetriol sulfate* levels in chronic kidney disease | GCST90265866 | 0.06 |
| 5454 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500918 | 0.06 |
| 5455 | AMY2B levels | GCST90468299 | 0.06 |
| 5456 | Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591) | GCST90269688 | 0.06 |
| 5457 | Free cholesterol to total lipids ratio in very small VLDL | GCST90093033 | 0.06 |
| 5458 | GP1BA levels | GCST90469380 | 0.06 |
| 5459 | Physical activity | GCST90093324 | 0.06 |
| 5460 | Shoulder width to body height ratio | GCST90270261 | 0.06 |
| 5461 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243 | ECGU000243 | 0.06 |
| 5462 | CRIP2/SNCG ratio | GCST90314262 | 0.06 |
| 5463 | Concentration of small VLDL particles (UKB data field 23509) | GCST90269606 | 0.06 |
| 5464 | ABO levels | GCST90468191 | 0.06 |
| 5465 | Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) | FING00000410 | 0.06 |
| 5466 | aparc-DKTatlas rh volume precentral | GCST90002915 | 0.06 |
| 5467 | Suggestive for eosinophilic asthma | FING00001344 | 0.06 |
| 5468 | Rhodanobacter abundance in stool | GCST90032536 | 0.06 |
| 5469 | APP/FKBP1B ratio | GCST90313323 | 0.06 |
| 5470 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242 | ECGU000242 | 0.06 |
| 5471 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T240 | ECGU000240 | 0.06 |
| 5472 | FAM172A levels | GCST90469184 | 0.06 |
| 5473 | LECT2 levels | GCST90469751 | 0.06 |
| 5474 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502596 | 0.06 |
| 5475 | Substance dependence | GCST90018704 | 0.06 |
| 5476 | Other retinal disorders | FING00001094 | 0.06 |
| 5477 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458 | ECGU000458 | 0.06 |
| 5478 | DLK1/PIK3IP1 ratio | GCST90314492 | 0.06 |
| 5479 | PDP1 levels | GCST90424296 | 0.06 |
| 5480 | Volume of left lateral nucleus | GCST90474889 | 0.06 |
| 5481 | CA5A levels | GCST90468514 | 0.06 |
| 5482 | CNDP1/F9 ratio | GCST90314147 | 0.06 |
| 5483 | Phospholipids in small VLDL (UKB data field 23511) | GCST90269608 | 0.06 |
| 5484 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T200 | ECGA000200 | 0.06 |
| 5485 | Glycated hemoglobin levels | GCST90566424 | 0.06 |
| 5486 | Concentration of very large HDL particles (UKB data field 23551) | GCST90269648 | 0.06 |
| 5487 | GABBR2 levels | GCST90241230 | 0.06 |
| 5488 | Anal and rectal conditions | digestive | UKBB00000029 | 0.06 |
| 5489 | ANXA3/EDAR ratio | GCST90313280 | 0.06 |
| 5490 | CASP3/PDGFB ratio | GCST90313638 | 0.06 |
| 5491 | T1 FreeSurfer pial rh pericalcarine area | GCST90385842 | 0.06 |
| 5492 | Triglycerides in large HDL | GCST90497888 | 0.06 |
| 5493 | Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622) | GCST90269719 | 0.06 |
| 5494 | Paraproteinemia (PheCode 270.32) | GCST90475710 | 0.06 |
| 5495 | Acute appendicitis, with complications | FING00000019 | 0.06 |
| 5496 | TNFRSF13C/TNFSF13B ratio | GCST90315934 | 0.06 |
| 5497 | Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093043 | 0.06 |
| 5498 | TEK levels | GCST90012013 | 0.06 |
| 5499 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202 | ECGA000202 | 0.06 |
| 5500 | Cholesteryl esters to total lipids ratio in very large VLDL | GCST90093019 | 0.06 |
| 5501 | CD2AP/USP8 ratio | GCST90313784 | 0.06 |
| 5502 | Pelvic inlet width | GCST90448910 | 0.06 |
| 5503 | wg lh intensity-contrast rostralmiddlefrontal | GCST90003818 | 0.06 |
| 5504 | Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers) | FING00001330 | 0.06 |
| 5505 | Cholesterol in large VLDL (UKB data field 23498) | GCST90269595 | 0.06 |
| 5506 | Umbilical hernia | FING00001395 | 0.06 |
| 5507 | Monounsaturated fatty acid levels | GCST90092928 | 0.06 |
| 5508 | GFAP levels | GCST90469325 | 0.06 |
| 5509 | Diverticulitis (PheCode 562.2) | GCST90476077 | 0.06 |
| 5510 | CDH17/PTPRM ratio | GCST90313943 | 0.06 |
| 5511 | HDGF levels | GCST90469442 | 0.06 |
| 5512 | Total lipid levels in very small VLDL | GCST90093034 | 0.06 |
| 5513 | S100G levels | GCST90470519 | 0.06 |
| 5514 | Phosphatidylethanolamine_35:2_[M-H]1- levels | GCST90060260 | 0.06 |
| 5515 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115) | GCST90320678 | 0.06 |
| 5516 | ERBIN/SNAP29 ratio | GCST90314697 | 0.06 |
| 5517 | KLK8 levels | GCST90425492 | 0.06 |
| 5518 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320641 | 0.06 |
| 5519 | PDCD5 levels | GCST90470182 | 0.06 |
| 5520 | C36:4 Phosphatidylethanolamine levels in chronic kidney disease | GCST90257357 | 0.06 |
| 5521 | FCRL3 levels | GCST90469207 | 0.06 |
| 5522 | Subarachnoid haemorrhage | FING00001339 | 0.06 |
| 5523 | DTI TBSS L2 Superior longitudinal fasciculus R | GCST90384516 | 0.06 |
| 5524 | Free cholesterol in very large VLDL (UKB data field 23493) | GCST90269590 | 0.06 |
| 5525 | Diastolic blood pressure | GCST90301698 | 0.06 |
| 5526 | LMNB1 levels | GCST90469781 | 0.06 |
| 5527 | SHBG levels | UKBB00000767 | 0.06 |
| 5528 | Sphingomyelin_42:3_[M+H]1+ levels | GCST90060399 | 0.06 |
| 5529 | DTI TBSS MD Posterior thalamic radiation L | GCST90384601 | 0.06 |
| 5530 | Gonarthrosis | FING00000585 | 0.06 |
| 5531 | Concentration of small HDL particles | GCST90092951 | 0.06 |
| 5532 | Cholesterol in very large VLDL (UKB data field 23491) | GCST90269588 | 0.06 |
| 5533 | Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484) | GCST90269581 | 0.06 |
| 5534 | Concentration of large HDL particles (UKB data field 23558) | GCST90269655 | 0.06 |
| 5535 | PYDC1 levels | GCST90470397 | 0.06 |
| 5536 | wg lh intensity-contrast parstriangularis | GCST90003811 | 0.06 |
| 5537 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497863 | 0.06 |
| 5538 | CD69/CHMP1A ratio | GCST90313868 | 0.06 |
| 5539 | Phospholipids in small LDL | GCST90499673 | 0.06 |
| 5540 | ENTPD5 levels | GCST90241024 | 0.06 |
| 5541 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1 | ECGU000001 | 0.06 |
| 5542 | DTI autoptx L1 ilf l tract | GCST90385153 | 0.06 |
| 5543 | Cholesterol in large HDL (UKB data field 23561) | GCST90269658 | 0.06 |
| 5544 | PDGFRA levels | GCST90421093 | 0.06 |
| 5545 | Chronic obstructive pulmonary disease liability (machine learning-based score) | GCST90244098 | 0.06 |
| 5546 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168 | ECGU000168 | 0.06 |
| 5547 | Cholesteryl Esters in Medium VLDL | GCST90498939 | 0.06 |
| 5548 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 0.06 |
| 5549 | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | FING00000431 | 0.05 |
| 5550 | Linoleic acid levels | GCST90502009 | 0.05 |
| 5551 | aparc-DKTatlas lh volume parsopercularis | GCST90002878 | 0.05 |
| 5552 | CRADD/DARS1 ratio | GCST90314234 | 0.05 |
| 5553 | PIK3AP1 levels | GCST90470233 | 0.05 |
| 5554 | F2R levels | GCST90469168 | 0.05 |
| 5555 | Concentration of medium LDL particles | GCST90092911 | 0.05 |
| 5556 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 0.05 |
| 5557 | aparc-a2009s rh volume G-cuneus | GCST90003009 | 0.05 |
| 5558 | NCK2/VASH1 ratio | GCST90315526 | 0.05 |
| 5559 | Hypertension, essential | FING00000638 | 0.05 |
| 5560 | OLR1/OSM ratio | GCST90315583 | 0.05 |
| 5561 | Actinic keratosis (PheCode 702.1) | GCST90476204 | 0.05 |
| 5562 | Peak expiratory flow (UKB data field 3064) | GCST90468176 | 0.05 |
| 5563 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171 | ECGU000171 | 0.05 |
| 5564 | ALB levels | GCST90018725 | 0.05 |
| 5565 | Cholesteryl ester levels in medium LDL | GCST90092906 | 0.05 |
| 5566 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T212 | ECGU000212 | 0.05 |
| 5567 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162 | ECGU000162 | 0.05 |
| 5568 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204 | ECGA000204 | 0.05 |
| 5569 | Rash and other nonspecific skin eruption (PheCode 687.1) | GCST90476167 | 0.05 |
| 5570 | MELTF levels | GCST90469885 | 0.05 |
| 5571 | APP/LAMA4 ratio | GCST90313325 | 0.05 |
| 5572 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4 | ECGU000004 | 0.05 |
| 5573 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502147 | 0.05 |
| 5574 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 0.05 |
| 5575 | Pelvic width | GCST90448911 | 0.05 |
| 5576 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 0.05 |
| 5577 | ECM1 levels | GCST90469065 | 0.05 |
| 5578 | Lung function (FEV1/FVC) | GCST90025978 | 0.05 |
| 5579 | COQ7 levels | GCST90468831 | 0.05 |
| 5580 | LCAT levels | GCST90469745 | 0.05 |
| 5581 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 0.05 |
| 5582 | GFER/VASH1 ratio | GCST90314922 | 0.05 |
| 5583 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169 | ECGU000169 | 0.05 |
| 5584 | MLN/TNFRSF12A ratio | GCST90315459 | 0.05 |
| 5585 | CD46/THBD ratio | GCST90313836 | 0.05 |
| 5586 | Biological Mother: Cancer, Breast | GCST90475485 | 0.05 |
| 5587 | NCS1/NPY ratio | GCST90315527 | 0.05 |
| 5588 | Volume of left cortical nucleus | GCST90474964 | 0.05 |
| 5589 | ThalamNuclei lh volume PuA | GCST90002720 | 0.05 |
| 5590 | BCL2L11/VASH1 ratio | GCST90313485 | 0.05 |
| 5591 | Height (standard GWA) | GCST90267284 | 0.05 |
| 5592 | Hair colour (natural, before greying) - Dark brown | Sun exposure | UKBB00000297 | 0.05 |
| 5593 | Lysine levels | GCST90200402 | 0.05 |
| 5594 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8 | ECGU000008 | 0.05 |
| 5595 | SNAP25 levels | GCST90422083 | 0.05 |
| 5596 | aparc-Desikan rh volume cuneus | GCST90002805 | 0.05 |
| 5597 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T70 | ECGU000070 | 0.05 |
| 5598 | T1 FreeSurfer DK lh superiortemporal thickness | GCST90385651 | 0.05 |
| 5599 | Phospholipids in medium LDL | GCST90498832 | 0.05 |
| 5600 | IRAK1/SPRY2 ratio | GCST90315196 | 0.05 |
| 5601 | DTI autoptx MD str l tract | GCST90385243 | 0.05 |
| 5602 | Mean volume of bilateral amygdala | GCST90474994 | 0.05 |
| 5603 | ITGB1/NCAM1 ratio | GCST90315227 | 0.05 |
| 5604 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75) | GCST90320894 | 0.05 |
| 5605 | Late-onset myasthenia gravis | GCST90432158 | 0.05 |
| 5606 | N6-methyllysine levels in chronic kidney disease | GCST90257530 | 0.05 |
| 5607 | Other noninfective gastroenteritis and colitis | FING00001077 | 0.05 |
| 5608 | CD19 on IgD- CD27- B cell | GCST90001732 | 0.05 |
| 5609 | Aplastic anemia | GCST90018574 | 0.05 |
| 5610 | IDP dMRI ProbtrackX ICVF ptr l | GCST90004394 | 0.05 |
| 5611 | BIN1 levels | GCST90090757 | 0.05 |
| 5612 | CHMP1A levels | GCST90619002 | 0.05 |
| 5613 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320947 | 0.05 |
| 5614 | C2/LILRB4 ratio | GCST90313554 | 0.05 |
| 5615 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440 | ECGU000440 | 0.05 |
| 5616 | Spondylolisthesis/Spondylolysis | FING00001324 | 0.05 |
| 5617 | Volume of right cortical nucleus | GCST90475030 | 0.05 |
| 5618 | HBEGF levels | GCST90012067 | 0.05 |
| 5619 | Fracture of shoulder and upper arm | FING00000559 | 0.05 |
| 5620 | BA-exvivo rh area MT | GCST90003232 | 0.05 |
| 5621 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320901 | 0.05 |
| 5622 | IDP T1 FAST ROIs R temporal pole | GCST90002466 | 0.05 |
| 5623 | T1 FreeSurfer BA lh V1 exvivo area | GCST90385514 | 0.05 |
| 5624 | Triglycerides in small VLDL (UKB data field 23515) | GCST90269612 | 0.05 |
| 5625 | Breast cancer | GCST010098 | 0.05 |
| 5626 | IRF3 levels | GCST90618743 | 0.05 |
| 5627 | Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621) | GCST90269718 | 0.05 |
| 5628 | Total lipids in small VLDL (UKB data field 23510) | GCST90269607 | 0.05 |
| 5629 | Trunk predicted mass | Impedance measures | UKBB00000866 | 0.05 |
| 5630 | Oblique pelvic inlet length | GCST90448909 | 0.05 |
| 5631 | aparc-a2009s rh area Pole-occipital | GCST90003412 | 0.05 |
| 5632 | DLK1/FAP ratio | GCST90314491 | 0.05 |
| 5633 | Heart failure and coronary heart disease | FING00000604 | 0.05 |
| 5634 | Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483) | GCST90269580 | 0.05 |
| 5635 | BCL2L11 levels | GCST90468430 | 0.05 |
| 5636 | Other menopausal disorders | FING00001071 | 0.05 |
| 5637 | CDH15 levels | GCST90468668 | 0.05 |
| 5638 | IDP T1 FAST ROIs L temporal pole | GCST90002465 | 0.05 |
| 5639 | Unspecified monoarthritis | musculoskeletal | UKBB00000882 | 0.05 |
| 5640 | Bullous keratopathy | FING00000231 | 0.05 |
| 5641 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 0.05 |
| 5642 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214 | ECGU000214 | 0.05 |
| 5643 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T199 | ECGA000199 | 0.05 |
| 5644 | PROK1 levels | GCST90470336 | 0.05 |
| 5645 | Hip circumference adjusted for BMI | GCST012227 | 0.05 |
| 5646 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T241 | ECGA000241 | 0.05 |
| 5647 | SWAP70 levels | GCST90242931 | 0.05 |
| 5648 | LAT/SERPINE1 ratio | GCST90315287 | 0.05 |
| 5649 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T151 | ECGU000151 | 0.05 |
| 5650 | Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481) | GCST90269578 | 0.05 |
| 5651 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452 | ECGU000452 | 0.05 |
| 5652 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 0.05 |
| 5653 | Symptoms concerning nutrition, metabolism, and development (PheCode 1002) | GCST90475556 | 0.05 |
| 5654 | Atrial fibrillation and flutter with reimbursement | FING00000127 | 0.05 |
| 5655 | HYOU1/ROR1 ratio | GCST90315104 | 0.05 |
| 5656 | Triglycerides x depression interaction (2df test) | GCST90570679 | 0.05 |
| 5657 | AHSA1 levels | GCST90468262 | 0.05 |
| 5658 | CDKN1A levels | GCST90468684 | 0.05 |
| 5659 | HDAC8 levels | GCST90469438 | 0.05 |
| 5660 | Elevated prostate specific antigen [PSA] (PheCode 796) | GCST90476277 | 0.05 |
| 5661 | CTSL levels | GCST90012073 | 0.05 |
| 5662 | SERPIND1 levels | GCST90470595 | 0.05 |
| 5663 | Free cholesterol to total lipids in large HDL percentage (UKB data field 23637) | GCST90269734 | 0.05 |
| 5664 | ADH4/CA5A ratio | GCST90313189 | 0.05 |
| 5665 | Other chondrocalcinosis | FING00000977 | 0.05 |
| 5666 | CLEC1B/DIABLO ratio | GCST90314087 | 0.05 |
| 5667 | Total lipids in VLDL (UKB data field 23424) | GCST90269521 | 0.05 |
| 5668 | Concentration of medium VLDL particles (UKB data field 23502) | GCST90269599 | 0.05 |
| 5669 | Unspecified osteomyelitis (PheCode 710.19) | GCST90476224 | 0.05 |
| 5670 | PARK7/TNFRSF9 ratio | GCST90315599 | 0.05 |
| 5671 | APOA4 levels | GCST90468333 | 0.05 |
| 5672 | DKK1/MGLL ratio | GCST90314473 | 0.05 |
| 5673 | Alkaline phosphatase | Blood biochemistry | UKBB00000027 | 0.05 |
| 5674 | Trunk fat-free mass | Impedance measures | UKBB00000865 | 0.05 |
| 5675 | CD300LG levels | GCST90468623 | 0.05 |
| 5676 | Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582) | GCST90269679 | 0.05 |
| 5677 | AGXT levels | GCST90468258 | 0.05 |
| 5678 | SCLY levels | GCST90470546 | 0.05 |
| 5679 | Mandibular retrognathia | FING00000784 | 0.05 |
| 5680 | IDP T1 FAST ROIs R cerebellum VI | GCST90002568 | 0.05 |
| 5681 | CRTAM/ICAM3 ratio | GCST90314276 | 0.05 |
| 5682 | AARSD1/PIK3AP1 ratio | GCST90313129 | 0.05 |
| 5683 | ACOX1/VSIR ratio | GCST90313155 | 0.05 |
| 5684 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T210 | ECGU000210 | 0.05 |
| 5685 | Congenital malformations of ovaries, fallopian tubes and broad ligaments | FING00000337 | 0.05 |
| 5686 | PLA2G4A/SPINT2 ratio | GCST90315671 | 0.05 |
| 5687 | Uterine leiomyomata | GCST90239856 | 0.05 |
| 5688 | Height | GCST90025949 | 0.05 |
| 5689 | S100A4/SNAP29 ratio | GCST90315801 | 0.05 |
| 5690 | CLC/RNASE3 ratio | GCST90314077 | 0.05 |
| 5691 | TPMT levels | GCST90470945 | 0.05 |
| 5692 | KCNA10 levels | GCST90617893 | 0.05 |
| 5693 | Ovarian cyst | FING00001132 | 0.05 |
| 5694 | Volume of right accessory basal nucleus | GCST90475006 | 0.05 |
| 5695 | HDL cholesterol levels | GCST90497352 | 0.05 |
| 5696 | Triglycerides to total lipids in very large HDL percentage (UKB data field 23633) | GCST90269730 | 0.05 |
| 5697 | Prostate cancer | GCST90428117 | 0.05 |
| 5698 | Gastric polyp | GCST90018630 | 0.05 |
| 5699 | Asthma-related infections | FING00000118 | 0.05 |
| 5700 | Cholesterol to Total Lipids in Small VLDL percentage | GCST90499764 | 0.05 |
| 5701 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 0.05 |
| 5702 | Treatment/medication code - gliclazide | Medications | UKBB00000846 | 0.04 |
| 5703 | Artrosis, including avohilmo | FING00000112 | 0.04 |
| 5704 | CLEC1A/TNFRSF1A ratio | GCST90314085 | 0.04 |
| 5705 | Internal derangement of knee | injuries & poisonings | UKBB00000368 | 0.04 |
| 5706 | Hayfever | GCST90468131 | 0.04 |
| 5707 | Saturated fatty acids to total fatty acids percentage | GCST90502696 | 0.04 |
| 5708 | Non-cancer illness year/age first occurred | Medical conditions | UKBB00000523 | 0.04 |
| 5709 | Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4) | GCST90475984 | 0.04 |
| 5710 | PCDH17/ROBO1 ratio | GCST90315604 | 0.04 |
| 5711 | CD27/ICAM3 ratio | GCST90313773 | 0.04 |
| 5712 | Crohn's disease NAS | FING00000367 | 0.04 |
| 5713 | Free cholesterol to total lipids ratio in very large VLDL | GCST90093021 | 0.04 |
| 5714 | Diseases of white blood cells (PheCode 288) | GCST90475812 | 0.04 |
| 5715 | AGXT/GRPEL1 ratio | GCST90313205 | 0.04 |
| 5716 | ThalamNuclei lh volume CM | GCST90002718 | 0.04 |
| 5717 | MET levels | GCST90469895 | 0.04 |
| 5718 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 0.04 |
| 5719 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25) | GCST90320588 | 0.04 |
| 5720 | OCLN levels | GCST90470114 | 0.04 |
| 5721 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320916 | 0.04 |
| 5722 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 0.04 |
| 5723 | CD274 levels | GCST90274832 | 0.04 |
| 5724 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 0.04 |
| 5725 | Open bite | FING00000903 | 0.04 |
| 5726 | Volume of left basal nucleus | GCST90474946 | 0.04 |
| 5727 | Operation year/age first occurred | Operations | UKBB00000570 | 0.04 |
| 5728 | MERTK levels | GCST90469890 | 0.04 |
| 5729 | Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels | GCST90060446 | 0.04 |
| 5730 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490 | ECGA000490 | 0.04 |
| 5731 | Free cholesterol in large VLDL (UKB data field 23500) | GCST90269597 | 0.04 |
| 5732 | LY6G6C levels | GCST90241830 | 0.04 |
| 5733 | Contracture of palmar fascia [Dupuytren's disease] (PheCode 728.71) | GCST90476245 | 0.04 |
| 5734 | X-24947 levels | GCST90200651 | 0.04 |
| 5735 | BCR/FOXO1 ratio | GCST90313490 | 0.04 |
| 5736 | Volume of left anterior amygdaloid area | GCST90474934 | 0.04 |
| 5737 | Phospholipids in very large VLDL (UKB data field 23490) | GCST90269587 | 0.04 |
| 5738 | CD40LG/EGF ratio | GCST90313819 | 0.04 |
| 5739 | DTI autoptx MD slf r tract | GCST90385242 | 0.04 |
| 5740 | CD55/CHI3L1 ratio | GCST90313845 | 0.04 |
| 5741 | YOD1 levels | GCST90471090 | 0.04 |
| 5742 | Citrate levels | GCST90092813 | 0.04 |
| 5743 | Right-hemisphere control network to amygdala white-matter structural connectivity | GCST90302841 | 0.04 |
| 5744 | Gonarthrosis, primary, with knee surgery | FING00000586 | 0.04 |
| 5745 | CLEC4D/CLEC6A ratio | GCST90314109 | 0.04 |
| 5746 | High cholesterol | GCST90475203 | 0.04 |
| 5747 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175 | ECGU000175 | 0.04 |
| 5748 | ANKMY2 levels | GCST90468309 | 0.04 |
| 5749 | Drusen (degenerative) of retina (PheCode 362.27) | GCST90475855 | 0.04 |
| 5750 | IDP T1 FAST ROIs L caudate | GCST90002549 | 0.04 |
| 5751 | ODAM levels | GCST90470115 | 0.04 |
| 5752 | Systemic lupus erythematosus | GCST90014238 | 0.04 |
| 5753 | Autorefraction - 3mm cylindrical power (left) | Eyesight | UKBB00000062 | 0.04 |
| 5754 | PDGFA/SNAP23 ratio | GCST90315619 | 0.04 |
| 5755 | Free cholesterol in small VLDL | GCST90499808 | 0.04 |
| 5756 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320879 | 0.04 |
| 5757 | Comparative height size at age 10 | Early life factors | UKBB00000143 | 0.04 |
| 5758 | Testosterone | Blood biochemistry | UKBB00000816 | 0.04 |
| 5759 | Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels | GCST90060148 | 0.04 |
| 5760 | Cholesteryl esters to total lipids ratio in small LDL | GCST90092959 | 0.04 |
| 5761 | EDAR/PRDX5 ratio | GCST90314583 | 0.04 |
| 5762 | WFIKKN2 levels | GCST90422127 | 0.04 |
| 5763 | HNRNPAB levels | GCST90088693 | 0.04 |
| 5764 | GDF2 levels | GCST90469322 | 0.04 |
| 5765 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 0.04 |
| 5766 | SERPINA9 levels | GCST90470588 | 0.04 |
| 5767 | FEV1 FVC ratio Z score (UKB data field 20258) | GCST90468165 | 0.04 |
| 5768 | CPA1/CTRC ratio | GCST90314204 | 0.04 |
| 5769 | KRT5 levels | GCST90469718 | 0.04 |
| 5770 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281 | ECGA000281 | 0.04 |
| 5771 | Monounsaturated fatty acid levels | GCST90499094 | 0.04 |
| 5772 | F7/PROC ratio | GCST90314744 | 0.04 |
| 5773 | Urolithiasis | GCST90018715 | 0.04 |
| 5774 | Concentration of small HDL particles | GCST90499464 | 0.04 |
| 5775 | Triacylglycerol (54:2) [NL-18:0] levels | GCST90025175 | 0.04 |
| 5776 | aparc-Desikan rh volume precentral | GCST90002824 | 0.04 |
| 5777 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244 | ECGU000244 | 0.04 |
| 5778 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498852 | 0.04 |
| 5779 | Treatment/medication code - ramipril | Medications | UKBB00000856 | 0.04 |
| 5780 | Retinal detachments and breaks | Disorders of choroid and retina | UKBB00000755 | 0.04 |
| 5781 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T155 | ECGU000155 | 0.04 |
| 5782 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 0.04 |
| 5783 | Physical activity (Total log acceleration 2am-4am) | GCST90061410 | 0.04 |
| 5784 | Right-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302790 | 0.04 |
| 5785 | CD58/MCAM ratio | GCST90313852 | 0.04 |
| 5786 | Gonarthrosis [arthrosis of knee] | Arthrosis | UKBB00000290 | 0.04 |
| 5787 | CCL25 levels | GCST90274768 | 0.04 |
| 5788 | DECR1/STX8 ratio | GCST90314452 | 0.04 |
| 5789 | BA-exvivo lh area V2 | GCST90003217 | 0.04 |
| 5790 | NT5E levels | GCST90470093 | 0.04 |
| 5791 | CRTAM/VCAM1 ratio | GCST90314281 | 0.04 |
| 5792 | Asthma (more control exclusions) | FING00000113 | 0.04 |
| 5793 | ASAH1 levels | GCST90468373 | 0.04 |
| 5794 | PRKAR1A levels | GCST90470326 | 0.04 |
| 5795 | KIR2DL3 levels | GCST90469685 | 0.04 |
| 5796 | TNFRSF14 levels | GCST90470907 | 0.04 |
| 5797 | Leucine levels | GCST90092891 | 0.04 |
| 5798 | Pregnancy hypertension | FING00001204 | 0.04 |
| 5799 | Whole body water mass (UKB data field 23102) | GCST90468184 | 0.04 |
| 5800 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282 | ECGA000282 | 0.04 |
| 5801 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320860 | 0.04 |
| 5802 | T1 FreeSurfer BA rh V1 exvivo area | GCST90385556 | 0.04 |
| 5803 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208 | ECGA000208 | 0.04 |
| 5804 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 0.04 |
| 5805 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T164 | ECGU000164 | 0.04 |
| 5806 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275 | ECGU000275 | 0.04 |
| 5807 | Total lipids in large VLDL (UKB data field 23496) | GCST90269593 | 0.04 |
| 5808 | NMI levels | GCST90470056 | 0.04 |
| 5809 | CASP3/CRKL ratio | GCST90313631 | 0.04 |
| 5810 | wg lh intensity-contrast superiorfrontal | GCST90003819 | 0.04 |
| 5811 | F3/GFRA1 ratio | GCST90314741 | 0.04 |
| 5812 | Free cholesterol in VLDL (UKB data field 23420) | GCST90269517 | 0.04 |
| 5813 | ITGB5 levels | GCST90469645 | 0.04 |
| 5814 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80) | GCST90320643 | 0.04 |
| 5815 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7) | GCST90320570 | 0.04 |
| 5816 | Volume of left medial nucleus | GCST90474892 | 0.04 |
| 5817 | Hair colour (natural, before greying): Blonde (UKB data field 1747_1) | GCST90041836 | 0.04 |
| 5818 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 0.04 |
| 5819 | Chronic sinusitis | FING00000298 | 0.04 |
| 5820 | ST13 levels | GCST90470751 | 0.04 |
| 5821 | KHK levels | GCST90469675 | 0.04 |
| 5822 | Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenum | UKBB00000606 | 0.04 |
| 5823 | Free cholesterol to total lipids ratio in IDL | GCST90092836 | 0.04 |
| 5824 | Cholesterol in Medium HDL | GCST90498492 | 0.04 |
| 5825 | FGF2/HBEGF ratio | GCST90314811 | 0.04 |
| 5826 | Paternal history of Alzheimer's disease | GCST005920 | 0.04 |
| 5827 | SUOX levels | GCST90470785 | 0.04 |
| 5828 | Total lipids in very large HDL (UKB data field 23552) | GCST90269649 | 0.04 |
| 5829 | Acute pancreatitis | GCST90255375 | 0.04 |
| 5830 | Female genital prolapse | FING00000535 | 0.04 |
| 5831 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 0.04 |
| 5832 | FLRT2 levels | GCST90469248 | 0.04 |
| 5833 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 0.04 |
| 5834 | RTN4R levels | GCST90470508 | 0.04 |
| 5835 | Secondary thrombocytopenia (PheCode 287.32) | GCST90475810 | 0.04 |
| 5836 | Lung function (FEV1/FVC) | GCST007431 | 0.04 |
| 5837 | IGFBPL1 levels | GCST90179323 | 0.04 |
| 5838 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167 | ECGU000167 | 0.04 |
| 5839 | Valine levels | GCST90500176 | 0.04 |
| 5840 | Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585) | GCST90269682 | 0.04 |
| 5841 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201 | ECGA000201 | 0.04 |
| 5842 | IDP dMRI TBSS ISOVF Corticospinal tract R | GCST90004483 | 0.04 |
| 5843 | Triglycerides in medium VLDL (UKB data field 23508) | GCST90269605 | 0.04 |
| 5844 | Ingrowing nail (PheCode 703.1) | GCST90476208 | 0.04 |
| 5845 | Kyphosis (MTAG) | GCST90570047 | 0.04 |
| 5846 | Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | GCST90475673 | 0.04 |
| 5847 | LGMN/SPINT2 ratio | GCST90315324 | 0.04 |
| 5848 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498714 | 0.04 |
| 5849 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501042 | 0.04 |
| 5850 | Breast cancer [female] | neoplasms | UKBB00000108 | 0.04 |
| 5851 | CLSTN3 levels | GCST90468790 | 0.04 |
| 5852 | GLA levels | GCST90469354 | 0.04 |
| 5853 | Multiple sclerosis | GCST90475833 | 0.04 |
| 5854 | Left bundle-branch block | FING00000716 | 0.04 |
| 5855 | MPHOSPH8/USP8 ratio | GCST90315479 | 0.04 |
| 5856 | Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | GCST90266045 | 0.04 |
| 5857 | Urinary calculus | genitourinary | UKBB00000886 | 0.04 |
| 5858 | Mean volume of bilateral amygdala | GCST90474901 | 0.04 |
| 5859 | SERPINA12 levels | GCST90470581 | 0.04 |
| 5860 | Phospholipids in medium LDL (UKB data field 23539) | GCST90269636 | 0.04 |
| 5861 | TNFSF11 levels | GCST90470918 | 0.04 |
| 5862 | aparc-a2009s rh volume S-parieto-occipital | GCST90003063 | 0.04 |
| 5863 | Knee osteoarthritis | GCST007090 | 0.04 |
| 5864 | aparc-a2009s rh area G-oc-temp-med-Lingual | GCST90003392 | 0.04 |
| 5865 | Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485) | GCST90269582 | 0.04 |
| 5866 | Concentration of large VLDL particles (UKB data field 23495) | GCST90269592 | 0.04 |
| 5867 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464) | GCST90269561 | 0.04 |
| 5868 | DTI TBSS MO Corticospinal tract R | GCST90384626 | 0.04 |
| 5869 | Diacylglycerol_36:4_[M+H-H2O]1+ levels | GCST90060188 | 0.04 |
| 5870 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 0.04 |
| 5871 | Disorders of breast | FING00000437 | 0.04 |
| 5872 | Operation code - caesarean section / caesarian section | Operations | UKBB00000552 | 0.04 |
| 5873 | Operation code - coronary angioplasty (ptca) +/- stent | Operations | UKBB00000555 | 0.04 |
| 5874 | Leucine levels (UKB data field 23466) | GCST90269563 | 0.04 |
| 5875 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 0.04 |
| 5876 | SIT1 levels | GCST90470644 | 0.04 |
| 5877 | Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers) | FING00000752 | 0.04 |
| 5878 | Phospholipids in medium LDL | GCST90498831 | 0.04 |
| 5879 | Abdominal aortic calcification levels | GCST90134614 | 0.04 |
| 5880 | Retinal thickness (functional principal component 6) | GCST90455726 | 0.04 |
| 5881 | Phospholipids in VLDL (UKB data field 23412) | GCST90269509 | 0.04 |
| 5882 | TTR levels | GCST90470985 | 0.04 |
| 5883 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T156 | ECGA000156 | 0.04 |
| 5884 | DTI autoptx L2 ifo l tract | GCST90385178 | 0.04 |
| 5885 | Volume of left central nucleus | GCST90474958 | 0.04 |
| 5886 | GUSB levels | GCST90469421 | 0.04 |
| 5887 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 0.04 |
| 5888 | CXCL5/MESD ratio | GCST90314350 | 0.04 |
| 5889 | Height | GCST90018739 | 0.04 |
| 5890 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165 | ECGU000165 | 0.04 |
| 5891 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 0.04 |
| 5892 | CDH5/LGALS4 ratio | GCST90313956 | 0.04 |
| 5893 | CNPY4/MESD ratio | GCST90314152 | 0.04 |
| 5894 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170 | ECGU000170 | 0.04 |
| 5895 | Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivity | GCST90302710 | 0.04 |
| 5896 | MCFD2 levels | GCST90469873 | 0.04 |
| 5897 | Cataract | sense organs | UKBB00000120 | 0.04 |
| 5898 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T211 | ECGA000211 | 0.04 |
| 5899 | DTI TBSS L3 Posterior corona radiata L | GCST90384551 | 0.04 |
| 5900 | Wet age-related macular degeneration | FING00001448 | 0.04 |
| 5901 | GGT1/IL1RL2 ratio | GCST90314929 | 0.04 |
| 5902 | Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) | GCST90475663 | 0.04 |
| 5903 | Triglycerides in large HDL | GCST90497882 | 0.04 |
| 5904 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37) | GCST90320856 | 0.04 |
| 5905 | ICD10 D25: Leiomyoma of uterus | GCST90454204 | 0.04 |
| 5906 | CD209/ITGAV ratio | GCST90313753 | 0.04 |
| 5907 | Concentration of VLDL particles (UKB data field 23428) | GCST90269525 | 0.04 |
| 5908 | Macular cyst | FING00000743 | 0.04 |
| 5909 | Retinal detachment with retinal defect | sense organs | UKBB00000754 | 0.04 |
| 5910 | MGLL levels | GCST90469901 | 0.04 |
| 5911 | ITGAL levels | GCST90469637 | 0.04 |
| 5912 | JAM2/THBD ratio | GCST90315239 | 0.04 |
| 5913 | CAG-273 sp003507395 abundance in stool | GCST90032269 | 0.04 |
| 5914 | Psoriasis vulgaris | GCST90018687 | 0.04 |
| 5915 | Other intervertebral disk disorders | Other dorsopathies | UKBB00000612 | 0.04 |
| 5916 | DTI TBSS L3 Posterior corona radiata R | GCST90384550 | 0.04 |
| 5917 | Chronic obstructive pulmonary disease in ever smokers | GCST90016588 | 0.04 |
| 5918 | SSNA1 levels | GCST90470750 | 0.04 |
| 5919 | Caries in Clefts patients | FING00000256 | 0.04 |
| 5920 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502372 | 0.04 |
| 5921 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 0.04 |
| 5922 | IDP dMRI TBSS MD Posterior limb of internal capsule L | GCST90004046 | 0.04 |
| 5923 | Pulse rate | Arterial stiffness | UKBB00000722 | 0.04 |
| 5924 | NPY levels | GCST90470081 | 0.04 |
| 5925 | aseg rh volume choroid-plexus | GCST90002646 | 0.04 |
| 5926 | GZMA levels | GCST90469423 | 0.04 |
| 5927 | T1 FreeSurfer a2009s rh G cuneus volume | GCST90385048 | 0.03 |
| 5928 | ROR1/TNFRSF21 ratio | GCST90315787 | 0.03 |
| 5929 | CXADR/MME ratio | GCST90314329 | 0.03 |
| 5930 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478 | ECGU000478 | 0.03 |
| 5931 | MLN levels | GCST90469913 | 0.03 |
| 5932 | Left ventricular end diastole anterior wall thickness | GCST90278518 | 0.03 |
| 5933 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 0.03 |
| 5934 | aparc-pial rh area cuneus | GCST90003178 | 0.03 |
| 5935 | ThalamNuclei lh volume VLp | GCST90002734 | 0.03 |
| 5936 | aparc-a2009s lh area S-oc-middle+Lunatus | GCST90003353 | 0.03 |
| 5937 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253 | ECGU000253 | 0.03 |
| 5938 | VNN2 levels | GCST90618510 | 0.03 |
| 5939 | GPI levels | GCST90241269 | 0.03 |
| 5940 | Dissociative [conversion] disorders | FING00000468 | 0.03 |
| 5941 | Left-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302740 | 0.03 |
| 5942 | SEMA3G levels | GCST90470571 | 0.03 |
| 5943 | 1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels | GCST90200057 | 0.03 |
| 5944 | Scoliosis | FING00001281 | 0.03 |
| 5945 | IDP dMRI ProbtrackX FA ptr r | GCST90003945 | 0.03 |
| 5946 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105) | GCST90320924 | 0.03 |
| 5947 | TTN levels | GCST90470984 | 0.03 |
| 5948 | Non-cancer illness code, self-reported - diabetes | Medical conditions | UKBB00000508 | 0.03 |
| 5949 | FEV1/FVC ratio | Other measurement | UKBB00000245 | 0.03 |
| 5950 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502051 | 0.03 |
| 5951 | aparc-a2009s rh volume S-oc-temp-med+Lingual | GCST90003059 | 0.03 |
| 5952 | wg lh intensity-contrast isthmuscingulate | GCST90003801 | 0.03 |
| 5953 | EGFR/FAP ratio | GCST90314613 | 0.03 |
| 5954 | aparc-Desikan rh area pericalcarine | GCST90003127 | 0.03 |
| 5955 | IDP dMRI TBSS L1 Fornix | GCST90004080 | 0.03 |
| 5956 | ANXA4/HSPB1 ratio | GCST90313292 | 0.03 |
| 5957 | CCN5/IGFBP6 ratio | GCST90313723 | 0.03 |
| 5958 | Optic cup area | GCST004137 | 0.03 |
| 5959 | LHPP levels | GCST90469768 | 0.03 |
| 5960 | FABP1/LGALS4 ratio | GCST90314752 | 0.03 |
| 5961 | Phospholipids in small VLDL | GCST90499881 | 0.03 |
| 5962 | Operation code - appendicectomy | Operations | UKBB00000549 | 0.03 |
| 5963 | Disorders of the thyroid gland | FING00000463 | 0.03 |
| 5964 | MESD/SNX9 ratio | GCST90315423 | 0.03 |
| 5965 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163 | ECGU000163 | 0.03 |
| 5966 | CLPS levels | GCST90468786 | 0.03 |
| 5967 | CDHR2/MME ratio | GCST90313963 | 0.03 |
| 5968 | Volume of left lateral nucleus | GCST90474973 | 0.03 |
| 5969 | ECHS1 levels | GCST90469063 | 0.03 |
| 5970 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502554 | 0.03 |
| 5971 | DPEP1 levels | GCST90469030 | 0.03 |
| 5972 | T1 CAT volume Vermis VIIIa | GCST90384128 | 0.03 |
| 5973 | Hallux valgus (acquired) | FING00000601 | 0.03 |
| 5974 | Diastolic blood pressure | GCST90301700 | 0.03 |
| 5975 | EBAG9 levels | GCST90469059 | 0.03 |
| 5976 | Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers) | FING00000877 | 0.03 |
| 5977 | Skin colour | Sun exposure | UKBB00000773 | 0.03 |
| 5978 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73 | ECGU000073 | 0.03 |
| 5979 | Phenylalanine levels | GCST90092936 | 0.03 |
| 5980 | KIAA0040 levels | GCST90422552 | 0.03 |
| 5981 | Cholelithiasis | FING00000275 | 0.03 |
| 5982 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266 | ECGU000266 | 0.03 |
| 5983 | THY1 levels | GCST90470861 | 0.03 |
| 5984 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41 | ECGA000041 | 0.03 |
| 5985 | Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044) | GCST90042535 | 0.03 |
| 5986 | GSTA4 levels | GCST90241283 | 0.03 |
| 5987 | Total esterified cholesterol levels | GCST90500036 | 0.03 |
| 5988 | Triglyceride levels in medium HDL | GCST90092902 | 0.03 |
| 5989 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 0.03 |
| 5990 | IDP dMRI TBSS FA External capsule R | GCST90003909 | 0.03 |
| 5991 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T269 | ECGA000269 | 0.03 |
| 5992 | BA-exvivo lh area BA4p | GCST90003212 | 0.03 |
| 5993 | FUCA1 levels | GCST90469275 | 0.03 |
| 5994 | AOC3 levels | GCST90468322 | 0.03 |
| 5995 | IDP dMRI TBSS MO Superior corona radiata L | GCST90003977 | 0.03 |
| 5996 | X-11444 metabolite level | GCST90616545 | 0.03 |
| 5997 | Atrophic disorders of skin | FING00000129 | 0.03 |
| 5998 | Retinal detachments and defects | sense organs | UKBB00000756 | 0.03 |
| 5999 | PDCD1/TNFRSF8 ratio | GCST90315610 | 0.03 |
| 6000 | Malignant melanoma | GCST90468141 | 0.03 |